Experience of NHS diagnostic investigation following a multi-cancer early detection (MCED) screening test: qualitative interviews with NHS-Galleri trial participants who had a cancer signal detected
This work was funded and sponsored by GRAIL Bio UK, Ltd. as a sub-study within the NHS-Galleri trial. GRAIL funded the costs of the data collection as well as staff salaries through a contract with King's College London/Queen Mary University of London.
Authors
- Ninian Schmeising-Barnes (ORCID: https://orcid.org/0000-0003-0136-6197)
- Laura A.V. Marlow (ORCID: https://orcid.org/0000-0003-1709-2397)
- Jo Waller
Institutions
- Queen Mary University of London (GB)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103733
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00